PPO services and formulary types
PPOS are seeing a continued resurgence in some areas, and in others, are not able to compete effectively with HMOs, industry experts say.
PPOS ARE EXPERIENCING a continued resurgence in some areas, and in others, are not able to compete effectively with HMOs, industry experts say.
Healthcare Benefits Consultant F. Randy Vogenberg, RPh, PhD, chief strategic officer and co-founder of Employer-based Pharmaceutical Strategies, LLC, based in Cranston, Rhode Island, agrees that PPOs need to differentiate their networks within the marketplace so that employers get a sense of receiving value for their premium dollars.
PPO SERVICES
According to Paduda, there is continued interest in ancillary care services, but it is geographically specific.
"For example, there is likely more interest in wellness and chiropractic in some areas than in others," he explains. "PPOs looking to expand market share in specific areas would do well to carefully research each area they operate to determine what potential customers are seeking."
As far as PPO formulary types go, there appears to be no differentiation or value seen in formulary decisions by PPOs at this point, with only a handful of exceptions, according to Dr. Vogenberg.
"Care quality and premium value remains elusive to payers," he says.
-Tracey WalkerCommentary is independent of source data
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More
